OTC Healthcare in Bosnia-Herzegovina
Euromonitor International's OTC Healthcare in Bosnia-Herzegovina market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 12 | Publication date: Mar 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
2005 witnessed the lowest growth over the review period
The OTC healthcare market in Bosnia-Herzegovina experienced moderate current value growth of 4% in 2005, which was the lowest growth witnessed over the review period. This is partly because Bosnians prefer to purchase medication that is either partially or wholly covered by the improving standards of health insurance.
However, significant changes regarding healthcare policies are expected in 2006 which will change this trend in favour of OTC healthcare purchases. This will be the result of self-medication becoming cheaper and faster compared with visits to the doctor.
Increased consumption of medication
The consumption of medicines in Bosnia-Herzegovina increased year-on-year, alongside the cost. Costs rose due to an increased number of prescribed medicines and the development and launch of new, more expensive medicines.
Pharmaceutical companies spend large amounts on marketing their products. So-called lifestyle drugs, ie drugs that are designed to treat the effects of modern lifestyles, are becoming more widely available. However, as these products were quite expensive, they did not record significant sales over the last few years of the review period.
Self-medicating becomes increasingly popular
Although Bosnia-Herzegovina has a low per capita consumption of OTC healthcare products, such products are becoming increasingly popular. However, volume consumption still depends on the kind of product, the age of the consumer group and the area of Bosnia-Herzegovina. Most sales take place in large cities and industrialised areas where the pace of lifestyle is much faster than in rural areas.
The young generations in cities and towns prefer OTC healthcare products. These people are aware of the problems of air pollution, stressful lifestyles, drinking and smoking and they want to protect themselves. They are also more responsive to advertising. As they dedicate most of their time to their careers, they do not have time to visit the doctor for a prescription, except for serious illnesses. Therefore, they usually buy more as well as more expensive OTC healthcare products.
The older generation and rural inhabitants usually have more time and less money than those who live in urban areas. They prefer to visit a doctor and wait for a prescription and thus save money.
Leading companies increased their control
The five leading manufacturers either increased or maintained their market value shares in 2005. Natural Life SA was the undisputed leader of OTC healthcare. Bosnia-Herzegovina is a small country; therefore the top five companies, which are all from former Yugoslavian republics, accounted for over one third of total 82current value sales in 2005.
Segmentation was one of the key drivers in sales of many OTC healthcare products. The leading players successfully expanded their product ranges around new formats and shapes, targeting their products to different age groups or different kinds of ailments.
Leading manufacturers such as Natural Life, Bosnalijek, Krka, Pliva, Lek and Hemofarm increased promotional campaigns and widened distribution channels.
Forecast showing more optimistic figures
Forecast figures for OTC healthcare are more optimistic, with sales expected to increase by 26% in constant value terms over the 2005-2010 period. Single vitamins is predicted to be the fastest growing product group.
From 2004, Rx products have been reimbursed only partially and the surcharges are expected to increase over the forecast period. This is expected to result in increased popularity of OTC healthcare products.
Table of contents
OTC HEALTHCARE IN BOSNIA-HERZEGOVINA : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Life Expectancy
Table 1 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 2 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
Table 3 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Competitive Environment
Table 4 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 5 OTC Healthcare Brand Shares by Retail Value 2002-2005
Leading Company Profile: Bosnalijek Pharmaceuticals dd
Summary 1 Bosnalijek dd: Operational Indicators 2005
Summary 2 Bosnalijek dd: Production Statistics 2005
Leading Company Profile: Krka dd
Summary 3 Krka dd: Operational Indicators 2005
New Product Developments
Retail Distribution
Table 6 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 7 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Forecast Market Performance
Table 8 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
Table 9 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS